Nasdaq · Healthcare
Alector, Inc. (ALEC)
As-reported financials and recent SEC filings for Alector, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$21.0M
Net income
$-142.9M
Net margin
—
Diluted EPS
$-1.39
ROE
-466.3%
P/E (TTM)
—
Market cap
—
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.0M | $100.6M | $97.1M | $133.6M | $207.1M |
| Gross profit | — | — | — | — | — |
| Operating income | $-156.0M | $-145.0M | $-151.7M | $-137.8M | $-37.4M |
| Net income | $-142.9M | $-119.0M | $-130.4M | $-133.3M | $-36.3M |
| Diluted EPS | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →8-K2026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →Largest Healthcare peers
Go deeper on ALEC
Search Alector, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.